Workflow
Beta Bionics, Inc.
icon
Search documents
KLAR INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Klarna Group plc (KLAR) Investors of Securities Class Action Deadline on February 20, 2026
Prnewswire· 2026-02-19 14:33
KLAR INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Klarna Group plc (KLAR) Investors of Securities Class Action Deadline on February 20, 2026 [Accessibility Statement] Skip NavigationFaruqi & Faruqi, LLP Securities Litigation Partner [James (Josh) Wilson] Encourages Investors Who Suffered Losses In Klarna To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in [Klarna] pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Regist ...
Beta Bionics, Inc. Q4 2025 Earnings Call Summary
Yahoo Finance· 2026-02-18 13:30
Achieved $100.3 million in 2025 net sales, representing 54% year-over-year growth driven by a doubling of the installed base to 35,000 users. Attributed sales force productivity to the iLet's fully automated algorithm and digital ecosystem, which allowed a smaller team of 63 territories to compete effectively against larger incumbents. Successfully executed a pharmacy channel strategy, establishing formulary agreements with all major U.S. PBMs to lower patient out-of-pocket costs and drive high-margin ...
Beta Bionics to Host Investor Event on June 22, 2025
Globenewswire· 2025-04-09 11:30
IRVINE, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced diabetes management solutions, today announced that it will host an investor event on Sunday, June 22, 2025, in conjunction with the 85th Scientific Sessions of the American Diabetes Association (ADA) taking place June 20-23, 2025, in Chicago, IL. The event will begin at 7:00 am Central Time (8:00 am Eastern Time) and conclude at approximately 8:30 am Centr ...